Literature DB >> 17055536

Metabolic changes during carcinogenesis: potential impact on invasiveness.

Kieran Smallbone1, Robert A Gatenby, Robert J Gillies, Philip K Maini, David J Gavaghan.   

Abstract

Successful adaptation to varying microenvironmental constraints plays a crucial role during carcinogenesis. We develop a hybrid cellular automation approach to investigate the cell-microenvironmental interactions that mediate somatic evolution of cancer cells. This allows investigation of the hypothesis that regions of premalignant lesions develop a substrate-limited environment as proliferation carries cells away from blood vessels which remain separated by the intact basement membrane. We find that selective forces in tumoural regions furthest from the blood supply act to favour cells whose metabolism is best suited to respond to local changes in oxygen, glucose and pH levels. The model predicts three phases of somatic evolution. Initially, cell survival and proliferation is limited due to diminished oxygen levels. This promotes adaptation to a second phase of growth dominated by cells with constitutively up-regulated glycolysis, less reliant on oxygen for ATP production. Increased glycolysis induces acidification of the local environment, limiting proliferation and inducing cell death through necrosis and apoptosis. This promotes a third phase of cellular evolution, with emergence of phenotypes resistant to acid-induced toxicity. This emergent cellular phenotype has a significant proliferative advantage because it will consistently acidify the local environment in a way that is toxic to its competitors but harmless to itself. The model's results suggest this sequence is essential in the transition from self-limited premalignant growth to invasive cancer, and, therefore, that this transition may be delayed or prevented through novel strategies directed towards interrupting the hypoxia-glycolysis-acidosis cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055536     DOI: 10.1016/j.jtbi.2006.09.010

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  62 in total

Review 1.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

Review 2.  Tumor cell metabolism: an integral view.

Authors:  Susana Romero-Garcia; Jose Sullivan Lopez-Gonzalez; José Luis Báez-Viveros; Dolores Aguilar-Cazares; Heriberto Prado-Garcia
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

3.  Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Authors:  Mark Robertson-Tessi; Robert J Gillies; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

4.  Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study.

Authors:  Chaim B Colen; Yimin Shen; Farhad Ghoddoussi; Pingyang Yu; Todd B Francis; Brandon J Koch; Michael D Monterey; Matthew P Galloway; Andrew E Sloan; Saroj P Mathupala
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

5.  An integrative computational model for intestinal tissue renewal.

Authors:  I M M van Leeuwen; G R Mirams; A Walter; A Fletcher; P Murray; J Osborne; S Varma; S J Young; J Cooper; B Doyle; J Pitt-Francis; L Momtahan; P Pathmanathan; J P Whiteley; S J Chapman; D J Gavaghan; O E Jensen; J R King; P K Maini; S L Waters; H M Byrne
Journal:  Cell Prolif       Date:  2009-07-20       Impact factor: 6.831

6.  Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.

Authors:  Michael H Muders; Heyu Zhang; Enfeng Wang; Donald J Tindall; Kaustubh Datta
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

7.  Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift?

Authors:  Jacob G Scott; David Basanta; Prakash Chinnaiyan; Peter Canoll; Kristen R Swanson; Alexander R A Anderson
Journal:  Neuro Oncol       Date:  2011-07-22       Impact factor: 12.300

8.  Episodic, transient systemic acidosis delays evolution of the malignant phenotype: Possible mechanism for cancer prevention by increased physical activity.

Authors:  Kieran Smallbone; Philip K Maini; Robert A Gatenby
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

9.  A theoretical quantitative model for evolution of cancer chemotherapy resistance.

Authors:  Ariosto S Silva; Robert A Gatenby
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

10.  Evolution of cell motility in an individual-based model of tumour growth.

Authors:  P Gerlee; A R A Anderson
Journal:  J Theor Biol       Date:  2009-03-12       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.